Release Date: 03/05/23 09:22 Summary: Non-Renounceable Issue Price Sensitive: Yes Download Document 407.09KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%